We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sanofi (PK) | USOTC:SNYNF | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.368 | 0.34% | 108.368 | 104.16 | 111.13 | 109.06 | 105.25 | 107.50 | 1,228 | 22:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
Specialized Disclosure Report
SANOFI
(Exact name of registrant as specified in its charter)
Republic of France | 001-31368 | 98-0346613 | ||
(State or other jurisdiction | (Commission | (IRS Employer | ||
of incorporation or organization) | File Number) | Identification No.) | ||
46 avenue de la Grande Armée Paris, France | 75017 | |||
(Address of principal executive offices) | (Zip Code) |
Alexandra Roger
(33) 1 53 77 48 98
(Name and telephone number, including area code, of the person to contact in connection with this report.)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
x | Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2022. |
Section 1 Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report
Conflict Minerals Disclosure
Sanofi (including its consolidated subsidiaries, the Company) is filing this Form SD pursuant to Rule 13p-1 under the Securities Exchange Act of 1934 (Rule 13p-1) for the reporting period from January 1, 2022 to December 31, 2022 (the Reporting Period).
Rule 13p-1, through Form SD, requires disclosure of certain information if a company manufactures or contracts to manufacture products for which certain conflict minerals (as defined below) are necessary to the functionality or production of such products. Form SD defines conflict minerals as: (i) (a) columbite-tantalite, (b) cassiterite, (c) gold and (d) wolframite, or their derivatives, which are currently limited to tantalum, tin and tungsten; or (ii) any other mineral or its derivatives determined by the U.S. Secretary of State to be financing conflict in the Democratic Republic of the Congo or an adjoining country, as such term is defined in Form SD (collectively, the Covered Countries).
The Companys operations may at times manufacture, or contract to manufacture, products for which conflict minerals are necessary to the functionality or production of those products (collectively, the products).
Reasonable Country of Origin Inquiry
As required by Form SD, the Company has conducted a good faith reasonable country of origin inquiry (RCOI) regarding the conflict minerals that are necessary to the functionality or production of its products during the Reporting Period, which the Company refers to as the Subject Minerals, to determine whether any such Subject Minerals originated in the Covered Countries and/or whether any of the Subject Minerals were from recycled or scrap sources, in accordance with Form SD and related guidance provided by the Securities and Exchange Commission (SEC). In accordance with SEC Staff Guidance with respect to Rule 13p-1, the Company excluded packaging materials from this review.
The Companys global supply chain is complex. In the course of its business operations, the Company may purchase materials and components containing Subject Minerals. These materials and components may, in turn, be included in the Companys products. Because the Company does not purchase conflict minerals directly from mines, smelters or refiners, there are many third parties in the supply chain between the Company and the original sources of conflict minerals. The Companys immediate suppliers, in turn, typically are also downstream in the minerals supply chain and have similar challenges in achieving supply chain transparency. As a result, the Company relies on its direct suppliers of materials, with which the Company has business relationships, to provide information regarding the origin of any conflict minerals that are included in their products.
The Companys RCOI process and results regarding the Subject Minerals include as described below.
| The Companys procurement and manufacturing and supply departments worked together to search the Companys database to identify where Subject Minerals were used in its products. As a result of this process, the Company identified certain of its immediate, potentially in-scope suppliers of materials that provided materials or components containing Subject Minerals (collectively, the Covered Suppliers). |
| The Company put in place a consultation of the Covered Suppliers, with the assistance of a third-party service vendor (the Vendor) with expertise in supply chain due diligence, to assist in data collection and identifying risks of the presence of Subject Minerals originating from Covered Countries in the Companys products, using the Conflict Minerals Reporting Template (CMRT) published by the Responsible Materials Initiative. The Company, with the assistance of the Vendor, inventoried the responses received from the Covered Suppliers. |
| An escalation process was conducted with Covered Suppliers who continued to be non-responsive, despite reminders e-mails after the above contacts were made, or whose initial (or subsequent) response was not complete or otherwise warranted clarification or confirmation. Using a risk-based approach, the Company, with the assistance of the Vendor, evaluated responses from the Covered Suppliers. The Company, with the assistance of the Vendor, engaged certain Covered Suppliers, holding discussions to ensure that the Companys inquiries regarding conflict minerals were understood and complied with. |
On the basis of the RCOI process described above, the Company has no reason to believe that the Subject Minerals contained in its products during the Reporting Period may have originated in the Covered Countries and not from recycled or scrap sources.
As required by Form SD, the disclosure contained in this Form SD regarding the Companys RCOI is available on the Companys website located at http://www.sanofi.com. The content on, or accessible through, any web site referred to in this Form SD is not incorporated by reference into this Form SD unless expressly noted.
Item 1.02. | Exhibit. |
Not applicable.
Section 2 Exhibits
Item 2.01 Exhibits
Not applicable
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
SANOFI
By: /s/ Brendan OCallaghan |
Date: 30 May, 2023 | |
Name: Brendan OCallaghan |
||
Title: Executive Vice President, Manufacturing and Supply |
1 Year Sanofi (PK) Chart |
1 Month Sanofi (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions